315 related articles for article (PubMed ID: 27736030)
21. Biotransformation and detectability of the new psychoactive substances N,N-diallyltryptamine (DALT) derivatives 5-fluoro-DALT, 7-methyl-DALT, and 5,6-methylenedioxy-DALT in urine using GC-MS, LC-MS
Michely JA; Brandt SD; Meyer MR; Maurer HH
Anal Bioanal Chem; 2017 Feb; 409(6):1681-1695. PubMed ID: 27933361
[TBL] [Abstract][Full Text] [Related]
22. Phase I metabolic profiling of the synthetic cannabinoids THJ-018 and THJ-2201 in human urine in comparison to human liver microsome and cytochrome P450 isoenzyme incubation.
Gaunitz F; Thomas A; Fietzke M; Franz F; Auwärter V; Thevis M; Mercer-Chalmers-Bender K
Int J Legal Med; 2019 Jul; 133(4):1049-1064. PubMed ID: 30564916
[TBL] [Abstract][Full Text] [Related]
23. Metabolism of the active metabolite of quetiapine, N-desalkylquetiapine in vitro.
Bakken GV; Molden E; Knutsen K; Lunder N; Hermann M
Drug Metab Dispos; 2012 Sep; 40(9):1778-84. PubMed ID: 22688609
[TBL] [Abstract][Full Text] [Related]
24. In vitro and in vivo human metabolism of the synthetic cannabinoid AB-CHMINACA.
Erratico C; Negreira N; Norouzizadeh H; Covaci A; Neels H; Maudens K; van Nuijs AL
Drug Test Anal; 2015 Oct; 7(10):866-76. PubMed ID: 25865117
[TBL] [Abstract][Full Text] [Related]
25. Study of the in vitro and in vivo metabolism of the tryptamine 5-MeO-MiPT using human liver microsomes and real case samples.
Grafinger KE; Hädener M; König S; Weinmann W
Drug Test Anal; 2018 Mar; 10(3):562-574. PubMed ID: 28677880
[TBL] [Abstract][Full Text] [Related]
26. Phenethylamine-derived new psychoactive substances 2C-E-FLY, 2C-EF-FLY, and 2C-T-7-FLY: Investigations on their metabolic fate including isoenzyme activities and their toxicological detectability in urine screenings.
Wagmann L; Hempel N; Richter LHJ; Brandt SD; Stratford A; Meyer MR
Drug Test Anal; 2019 Oct; 11(10):1507-1521. PubMed ID: 31299701
[TBL] [Abstract][Full Text] [Related]
27. 2,5-Dimethoxyamphetamine-derived designer drugs: studies on the identification of cytochrome P450 (CYP) isoenzymes involved in formation of their main metabolites and on their capability to inhibit CYP2D6.
Ewald AH; Maurer HH
Toxicol Lett; 2008 Dec; 183(1-3):52-7. PubMed ID: 18938231
[TBL] [Abstract][Full Text] [Related]
28. Looking at flubromazolam metabolism from four different angles: Metabolite profiling in human liver microsomes, human hepatocytes, mice and authentic human urine samples with liquid chromatography high-resolution mass spectrometry.
Wohlfarth A; Vikingsson S; Roman M; Andersson M; Kugelberg FC; Green H; Kronstrand R
Forensic Sci Int; 2017 May; 274():55-63. PubMed ID: 27863836
[TBL] [Abstract][Full Text] [Related]
29. Opioid intoxications involving butyrfentanyl, 4-fluorobutyrfentanyl, and fentanyl from the Swedish STRIDA project.
Bäckberg M; Beck O; Jönsson KH; Helander A
Clin Toxicol (Phila); 2015; 53(7):609-17. PubMed ID: 26083809
[TBL] [Abstract][Full Text] [Related]
30. Identification of phase I and II metabolites of the new designer drug α-pyrrolidinohexiophenone (α-PHP) in human urine by liquid chromatography quadrupole time-of-flight mass spectrometry (LC-QTOF-MS).
Paul M; Bleicher S; Guber S; Ippisch J; Polettini A; Schultis W
J Mass Spectrom; 2015 Nov; 50(11):1305-17. PubMed ID: 26505776
[TBL] [Abstract][Full Text] [Related]
31. Application of liquid chromatography/mass spectrometry in accelerating the identification of human liver cytochrome P450 isoforms involved in the metabolism of iloperidone.
Mutlib AE; Klein JT
J Pharmacol Exp Ther; 1998 Sep; 286(3):1285-93. PubMed ID: 9732390
[TBL] [Abstract][Full Text] [Related]
32. Metabolism of the tryptamine-derived new psychoactive substances 5-MeO-2-Me-DALT, 5-MeO-2-Me-ALCHT, and 5-MeO-2-Me-DIPT and their detectability in urine studied by GC-MS, LC-MS
Caspar AT; Gaab JB; Michely JA; Brandt SD; Meyer MR; Maurer HH
Drug Test Anal; 2018 Jan; 10(1):184-195. PubMed ID: 28342193
[TBL] [Abstract][Full Text] [Related]
33. Metabolism of Butyrylfentanyl in Fresh Human Hepatocytes: Chemical Synthesis of Authentic Metabolite Standards for Definitive Identification.
Kanamori T; Iwata YT; Segawa H; Yamamuro T; Kuwayama K; Tsujikawa K; Inoue H
Biol Pharm Bull; 2019; 42(4):623-630. PubMed ID: 30930421
[TBL] [Abstract][Full Text] [Related]
34. Metabolic characterization of (1-(5-fluoropentyl)-1H-indol-3-yl)(4-methyl-1-naphthalenyl)-methanone (MAM-2201) using human liver microsomes and cDNA-overexpressed cytochrome P450 enzymes.
Kong TY; Kim JH; Choi WG; Lee JY; Kim HS; Kim JY; In MK; Lee HS
Anal Bioanal Chem; 2017 Feb; 409(6):1667-1680. PubMed ID: 27924364
[TBL] [Abstract][Full Text] [Related]
35. Comparative metabolism of tussilagone in rat and human liver microsomes using ultra-high-performance liquid chromatography coupled with high-resolution LTQ-Orbitrap mass spectrometry.
Zhang XS; Ren W; Bian BL; Zhao HY; Wang S
Rapid Commun Mass Spectrom; 2015 Sep; 29(18):1641-50. PubMed ID: 26467116
[TBL] [Abstract][Full Text] [Related]
36. Involvement of CYP3A4/5 and CYP2D6 in the metabolism of aconitine using human liver microsomes and recombinant CYP450 enzymes.
Tang L; Ye L; Lv C; Zheng Z; Gong Y; Liu Z
Toxicol Lett; 2011 Apr; 202(1):47-54. PubMed ID: 21277363
[TBL] [Abstract][Full Text] [Related]
37. In vitro metabolic profiling of synthetic cannabinoids by pooled human liver microsomes, cytochrome P450 isoenzymes, and Cunninghamella elegans and their detection in urine samples.
Gaunitz F; Dahm P; Mogler L; Thomas A; Thevis M; Mercer-Chalmers-Bender K
Anal Bioanal Chem; 2019 Jun; 411(16):3561-3579. PubMed ID: 31183523
[TBL] [Abstract][Full Text] [Related]
38. Liquid chromatography-quadrupole time-of-flight mass spectrometry for screening in vitro drug metabolites in humans: investigation on seven phenethylamine-based designer drugs.
Lai FY; Erratico C; Kinyua J; Mueller JF; Covaci A; van Nuijs AL
J Pharm Biomed Anal; 2015 Oct; 114():355-75. PubMed ID: 26112925
[TBL] [Abstract][Full Text] [Related]
39. Characterization and in vitro phase I microsomal metabolism of designer benzodiazepines - an update comprising adinazolam, cloniprazepam, fonazepam, 3-hydroxyphenazepam, metizolam and nitrazolam.
Moosmann B; Bisel P; Franz F; Huppertz LM; Auwärter V
J Mass Spectrom; 2016 Nov; 51(11):1080-1089. PubMed ID: 27535017
[TBL] [Abstract][Full Text] [Related]
40. Metabolite elucidation of the Hsp90 inhibitor SNX-2112 using ultraperformance liquid chromatography/quadrupole time-of-flight mass spectrometry (UPLC-QTOF/MS).
Liu W; Liu H; Sun H; Dong D; Ma Z; Wang Y; Wu B
Xenobiotica; 2014 May; 44(5):455-64. PubMed ID: 24191862
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
